How many patents does
Pfizer Products have?
patents
3,255
families
366
granted
916
applications
2,339
US
425
EP
308
CN
156
WO
68
KR
66
JP
66
RoW
2,166
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Pfizer Products
Top ten assignees appearing on patents
2009 - 2018
| pfizer products | 2121 |
| pfizer | 418 |
| bend research | 72 |
| zoetis p | 67 |
| zoetis services | 61 |
| novartis | 55 |
| bristol-myers squibb company | 49 |
| osi pharmaceuticals | 36 |
| amgen fremont | 33 |
| capsugel belgium | 30 |
2009
| pfizer products | 744 |
| pfizer | 107 |
| novartis | 19 |
| bend research | 7 |
| osi pharmaceuticals | 7 |
| pfajzer prodakts ink. | 5 |
| laennen tutkimus - western research | 3 |
| abgenix | 3 |
| amgen fremont | 3 |
| reilly, usa | 2 |
2018
| pfizer products | 21 |
| zoetis services | 17 |
| pfizer | 3 |
| capsugel belgium | 2 |
| novartis | 1 |
| zoetis p | 1 |
| pah usa 15 | 1 |
| osi pharmaceuticals | 1 |
| warner-lambert company | 1 |
| aspen global | 1 |
Pfizer Products
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| tricyclic compounds and their use as glucocorticoid receptor modulators | 95 | 2007 |
| benzimidazole derivatives | 61 | 2007 |
| pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors | 57 | 2006 |
| apixaban formulations | 53 | 2010 |
| sulfonyl amide derivatives for the treatment of abnormal cell growth | 46 | 2007 |
| antibodies to cd40 | 45 | 2001 |
| biaryl ether urea compounds | 42 | 2006 |
| pyrazoline compounds as mineralocorticoid receptor antagonists | 39 | 2006 |
| heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins | 37 | 2006 |
| substituted bicyclolactam compounds | 37 | 2007 |